AstraZeneca PLC (BCBA:AZN)

Argentina flag Argentina · Delayed Price · Currency is ARS
71,325
+1,825 (2.63%)
At close: Feb 10, 2026
Market Cap419.48T +84.3%
Revenue (ttm)79.66T +13.5%
Net Income12.88T +44.7%
EPS8,248.60 +45.0%
Shares Outn/a
PE Ratio32.57
Forward PE18.42
Dividend795.69 (1.15%)
Ex-Dividend DateAug 8, 2025
Volume93
Average Volume563
Open70,225
Previous Close69,500
Day's Range70,225 - 71,475
52-Week Range36,850 - 79,800
Betan/a
RSI46.61
Earnings DateFeb 10, 2026

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 94,300
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol AZN
Full Company Profile

Financial Performance

In 2024, AstraZeneca's revenue was $54.07 billion, an increase of 18.03% compared to the previous year's $45.81 billion. Earnings were $7.04 billion, an increase of 18.14%.

Financial numbers in USD Financial Statements